We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Agendia Raises €25 Million and Receives Second FDA Clearance

ING, one of the largest bank-insurers, becomes a shareholder of Agendia.
News

Ipsogen Grants Exclusive License to Warnex to Market a Leukemia Molecular Diagnostic Service in Canada

Ipsogen grants Warnex exclusive rights to market a service for the diagnosis and the classification of a group of leukemias.
News

BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University

BSD Medical gains exclusive rights to Duke’s treatment system for primary breast cancer using hyperthermia therapy.
News

A Study by the MUHC and McGill University Opens a new Door to Understanding Cancer

Study provides a key to understand the mechanisms that trigger cancer cell growth that may prove crucial to develop more targeted treatments for cancer.
News

GeneNews Secures $2 Million for Development of Prostate Biomarkers

GeneNews signs agreement with an Asian Biomedical consortium to develop blood-based biomarkers for the detection and management of prostate diseases.
News

Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia into Clinical Practice

Xenomics’ diagnostic test developed for stratification of patients with AML has been implemented at CLIA approved BRT Laboratories.
News

Eden Biodesign and the University of Manchester Intellectual Property Limited Develop Innovative Treatment for Cancer

UMIP selects Eden Biodesign to provide a range of services for the development of therapeutic for treatment of macular degeneration and cancer.
News

Ensemble Discovery and Roche Initiate Research Collaboration to Apply new Diagnostic Technology to Optimize Cancer Therapy

Collaboration will enable analysis of critical drug target family in patient cancer biopsies and selection of appropriate therapy.
News

Curidium Joins the Personalized Medicine Coalition

Curidium Medica plc has announced that it has joined the US-based Personalized Medicine Coalition.
News

eXludus Joins BioIT Alliance to Speed Life Sciences Research on Clusters and Grids

eXludus will contribute leadership in accelerating time-to-discovery through processing of biomedical applications and data across clusters and Grids.
Advertisement